Skip to main content
. 2021 Feb 2;10:604534. doi: 10.3389/fonc.2020.604534

Figure 2.

Figure 2

High expression of DNAJC3-AS1 is associated with poor prognosis of patients with CRC. (A) DNAJC3-AS1 expression measured by in situ hybridization in paraffin-embedded CRC biopsy samples. Upper panel: magnification = 20×; lower panel: magnification = 40×. (B, C) DNAJC3-AS1 expression is associated with TNM staging. (D) Highly expression of DNAJC3-AS1 is correlated with shorter overall survival. (*P < 0.05, **P < 0.01).